Clinical Trial Update: Evaluation of Safety, Immunogenicity, and Prevention of TB With AERAS-404 and BCG Revaccination in Healthy Adolescents [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety, immunogenicity, and prevention of tuberculosis with AERAS-404 and BCG revaccination in healthy adolescents completed; results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• AERAS 404
• BCG (Bacillus Calmette-Guérin)

Snippet

Sponsor: Aeras | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2019-07-29